Thrombospondin-1 contributes to mortality in murine sepsis through effects on innate immunity

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  McMaken, Sara ^a   Exline, Matthew C ^a   Mehta, Payal ^a   Piper, Melissa ^a   Wang, Yijie ^a   Fischer, Sara N ^a   Newland, Christie A ^a   Schrader, Carrie A ^a   Balser, Shannon R ^a   Sarkar, Anasuya ^a   Baran, Christopher P ^a   Marsh, Clay B ^a   Cook, Charles H ^b   Phillips, Gary S ^b   Ali, Naeem A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; AUTACOID; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; BACTERIAL STRAIN; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; FLOW CYTOMETRY; GENOTYPE; INNATE IMMUNITY; MACROPHAGE; MALE; MORTALITY; MOUSE; NONHUMAN; PERITONEAL CAVITY; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEPSIS; WILD ANIMAL; ANIMAL; BLOOD; CECUM; CELL COUNT; CELL PROTECTION; CYTOLOGY; DISEASE MODEL; HUMAN; IMMUNOLOGY; LIGATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PERITONEUM; PERITONEUM LAVAGE; PUNCTURE; SURVIVAL; WOUND HEALING;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; MUS;

ANIMALS; BACTERIAL LOAD; CECUM; CELL COUNT; CYTOKINES; CYTOPROTECTION; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; LIGATION; MACROPHAGES; MICE; PERITONEAL LAVAGE; PERITONEUM; PHAGOCYTOSIS; PUNCTURES; SEPSIS; SURVIVAL ANALYSIS; THROMBOSPONDIN 1; WOUND HEALING;

EID: 79955842992     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019654     Document Type: Article

References (42)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310.
2. Dellinger RP, (2003) Cardiovascular management of septic shock. Crit Care Med 31: 946-955.
3. Martin GS, Mannino DM, Eaton S, Moss M, (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554.
4. Cohen J, (2002) The immunopathogenesis of sepsis. Nature 420: 885-891.
5. Hotchkiss RS, Karl IE, (2003) The Pathophysiology and Treatment of Sepsis. N Engl J Med 348: 138-150.
6. Riche FC, Dray X, Laisne MJ, Mateo J, Raskine L, et al. (2009) Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis. Crit Care 13.
7. Esemuede N, Lee T, Pierre-Paul D, Sumpio BE, Gahtan V, (2004) The role of thrombospondin-1 in human disease. J Surg Res 122: 135-142.
8. Baenziger NL, Brodie GN, Majerus PW, (1971) A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci U S A 68: 240-243.
9. DiPietro LA, Nissen NN, Gamelli RL, Koch AE, Pyle JM, et al. (1996) Thrombospondin 1 synthesis and function in wound repair. Am J Pathol 148: 1851-1860.
10. Iruela-Arispe ML, Bornstein P, Sage H, (1991) Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci U S A 88: 5026-5030.
11. Gawaz M, Dickfeld T, Bogner C, Fateh-Moghadam S, Neumann FJ, (1997) Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med 23: 379-385.
12. Maloney JP, Strong D, Somberg L, Kraemer R, Zelazoski A, et al. (2002) Variant Polymorphisms in the Thrombospondin-1 (TSP-1) Gene in Patients with Acute Lung Injury. J Clin Invest 16: A879-A879.
13. Adams JC, Lawler J, (2004) The thrombospondins. Int J Biochem Cell Biol 36: 961-968.
14. Chen H, Herndon ME, Lawler J, (2000) The cell biology of thrombospondin-1. Matrix Biol 19: 597-614.
15. Igarashi A, Okochi H, Bradham DM, Grotendorst GR, (1993) Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4: 637-645.
16. Saltzman AK, Olson TA, Mohanraj D, Carson LF, Ramakrishnan S, (1996) Prevention of postoperative adhesions by an antibody to vascular permeability factor/vascular endothelial growth factor in a murine model. Am J Obstet Gynecol 174: 1502-1506.
17. Ali NA, Gaughan AA, Orosz CG, Baran CP, McMaken S, et al. (2008) Latency Associated Peptide Has In Vitro and In Vivo Immune Effects Independent of TGF-Beta1. PLoS ONE 3.
18. Narizhneva NV, Razorenova OV, Podrez EA, Chen J, Chandrasekharan UM, et al. (2005) Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium. FASEB J 04-3310fje.
19. Schultz-Cherry S, Lawler J, Murphy-Ullrich JE, (1994) The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. J Biol Chem 269: 26783-26788.
20. Pittet JF, Griffiths MJ, Geiser T, Kaminski N, Dalton SL, et al. (2001) TGF-beta is a critical mediator of acute lung injury. J Clin Invest 107: 1537-1544.
21. van der Wal JB, Jeekel J, (2007) Biology of the peritoneum in normal homeostasis and after surgical trauma. Colorectal Dis 9: 9-13.
22. Piazuelo E, Jimenez P, Lanas A, Garcia A, Esteva F, et al. (2000) Platelet-Derived Growth Factor and Epidermal Growth Factor Play a Major Role in Human Colonic Fibroblast Repair Activities. Eur Surg Res 32: 191-196.
23. Saed GM, Diamond MP, (2004) Molecular characterization of postoperative adhesions: the adhesion phenotype. J Am Assoc Gynecol Laparosc 11: 307-314.
24. Barker TH, Pallero MA, MacEwen MW, Tilden SG, Woods A, et al. (2004) Thrombospondin-1-induced focal adhesion disassembly in fibroblasts requires Thy-1 surface expression, lipid raft integrity, and Src activation. J Biol Chem 279: 23510-23516.
25. Aytekin FO, Teke Z, Aydin C, Kabay B, Yenisey C, et al. (2007) Effects of a membrane-permeable radical scavenger, Tempol, on healing of colonic anastomoses in the cecal ligation and puncture model of polymicrobial sepsis in rats. Am J Surg 193: 723-729.
26. Steinhauser ML, Hogaboam CM, Lukacs NW, Strieter RM, Kunkel SL, (1999) Multiple Roles for IL-12 in a Model of Acute Septic Peritonitis. J Immunol 162: 5437-5443.
27. Diamond MP, El Hammady E, Munkarah A, Bieber EJ, Saed G, (2005) Modulation of the expression of vascular endothelial growth factor in human fibroblasts. Fertil Steril 83: 405-409.
28. van Zoelen MA, Florquin D, Sandrine M, Joost CM, de Beer R, et al. (2008) Platelet-Activating Factor Receptor Contributes to Host Defense against Pseudomonas aeruginosa Pneumonia but Is Not Essential for the Accompanying Inflammatory and Procoagulant Response. J Immunol 180: 3357-3365.
29. Wirtz S, Tubbe I, Galle PR, Schild HJ, Birkenbach M, et al. (2006) Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med 203: 1875-1881.
30. Tridandapani S, Lyden TW, Smith JL, Carter JE, Coggeshall KM, et al. (2000) The adapter protein LAT enhances fcgamma receptor-mediated signal transduction in myeloid cells. J Biol Chem 275: 20480-20487.
31. Sarkar A, Hall MW, Exline M, Hart J, Knatz N, et al. (2006) Caspase-1 regulates Escherichia coli sepsis and splenic B cell apoptosis independently of interleukin-1beta and interleukin-18. Am J Respir Crit Care Med 174: 1003-1010.
32. Streit M, Velasco P, Riccardi L, Spencer L, Brown LF, et al. (2000) Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J 19: 3272-3282.
33. Lawler J, Sunday M, Thibert V, Duquette M, George EL, et al. (1998) Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J Clin Invest 101: 982-992.
34. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, et al. (1998) Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93: 1159-1170.
35. Yang Z, Mu Z, Dabovic B, Jurukovski V, Yu D, et al. (2007) Absence of integrin-mediated TGF{beta}1 activation in vivo recapitulates the phenotype of TGF{beta}1-null mice. J Cell Biol 176: 787-793.
36. Mansfield PJ, Suchard SJ, (1994) Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J Immunol 153: 4219-4229.
37. Martin-Manso G, Galli S, Ridnour LA, Tsokos M, Wink DA, et al. (2008) Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells. Cancer Res 68: 7090-7099.
38. Moodley Y, Rigby P, Bundell C, Bunt S, Hayashi H, et al. (2003) Macrophage recognition and phagocytosis of apoptotic fibroblasts is critically dependent on fibroblast-derived thrombospondin 1 and CD36. Am J Pathol 162: 771-779.
39. Ren Y, Savill J, (1995) Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis. J Immunol 154: 2366-2374.
40. Simms HH, D'Amico R, (1994) Polymorphonuclear leukocyte dysregulation during the systemic inflammatory response syndrome. Blood 83: 1398-1407.
41. Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, et al. (1998) Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill Patients. Ann Intern Med 129: 433-440.
42. Baran CP, Tridandapani S, Helgason CD, Humphries RK, Krystal G, et al. (2003) The inositol 5′-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity. J Biol Chem 278: 38628-38636.